Status:

UNKNOWN

Acute High Fat Bulletproof Coffee vs Black Coffee on Metabolism, Inflammation and Cognitive Function in Healthy Adults

Lead Sponsor:

University of British Columbia

Conditions:

Leukocytosis

Triglycerides

Eligibility:

All Genders

18-55 years

Phase:

NA

Brief Summary

This study will determine whether acute ingestion of a high fat "Bulletproof Coffee" will lead to changes in plasma triglycerides, immune cell function, as well as cognitive function when compared to ...

Detailed Description

In a randomized crossover design, participants will consume a single bulletproof coffee or a single black coffee separated by \~7 days. Each visit commences in the morning after an overnight fast of 1...

Eligibility Criteria

Inclusion

  • Must be over the age of 18
  • Must drink between 1-4 cups of coffee per day (on average)
  • Must be able to tolerate lactose and dairy products
  • Have not been sick for the past 3 weeks (immune function)
  • Non smoker
  • Must be able to fast for 10-12 hours

Exclusion

  • If you are required to take corticosteroids (immune function)
  • Cannot understand or speak English
  • Individual has an auto-immune disease and requires medication
  • Individual is following a ketogenic diet
  • Individual has allergy or sensitivity to dairy, coffee or caffeine or coconut oil
  • Individual has hypertension

Key Trial Info

Start Date :

January 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2020

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04307979

Start Date

January 1 2020

End Date

December 31 2020

Last Update

March 13 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of British Columbia, Okanagan.

Kelowna, British Columbia, Canada, V1V 1V7